At 6.8% CAGR, the Asia Pacific Diabetic Foot Ulcer Market is projected to be worth US$ 2,472.61 million by 2030, says Business Market Insights.

According to Business Market Insights' research, the Asia Pacific diabetic foot ulcer market was valued at US$ 1,455.82 in 2022 and is expected to reach US$ 2,472.61 million by 2030, registering a CAGR of 6.8% from 2022 to 2030. Growing research activities to unveil novel wound treatment products is among the critical factors attributed to the Asia Pacific diabetic foot ulcer market expansion.

Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. With the significant growth in the patient pool suffering from chronic wounds, such as diabetic foot ulcers, the need for a systematic treatment approach has accelerated, encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wound management have demonstrated that bioactive wound care products help heal moist wounds more effectively than traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in wound care treatments. For instance, in June 2021, Cynata Therapeutics Limited, an Australian clinical-stage stem cell and regenerative medicine company, signed a license agreement with TekCyte to advance clinical trials in diabetic foot ulcers. The growing research activities and initiative by players will provide lucrative opportunities for the market growth. 

On the contrary, high cost of advanced wound care treatments hampers the growth Asia Pacific diabetic foot ulcer market.

Based on treatment type, the Asia Pacific diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held 55.9% share of the Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 814.39 million. It is projected to garner US$ 1,407.87 million by 2030 to expand at 7.1% CAGR during 2022-2030.

Based on ulcer type, the Asia Pacific diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held 52.2% share of the Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 759.71 million. It is projected to garner US$ 1,321.16 million by 2030 to expand at 7.2% CAGR during 2022–2030.

Based on infection severity, the Asia Pacific diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held 48.5% share of Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 706.03 million. It is projected to garner US$ 1,236.98 million by 2030 to expand at 7.3% CAGR during 2022–2030.

Based on end user, the Asia Pacific diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held 56.7% share of Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 825.38 million. It is projected to garner US$ 1,453.59 million by 2030 to expand at 7.3% CAGR during 2022–2030.

Based on country, the Asia Pacific diabetic foot ulcer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China held 36.4% share of Asia Pacific diabetic foot ulcer market in 2022, amassing US$ 530.06 million. It is projected to garner US$ 885.44 million by 2030 to expand at 6.6% CAGR during 2022–2030.

Key players operating in the Asia Pacific diabetic foot ulcer market are Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, MiMedx Group Inc, and URGO Medical Australia Pty Ltd, among others.

• In Jan 2023, Convatec announced the launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com